Ping Zhou

发表

Selective and dual action orally active inhibitors of thrombin and factor Xa.

Stefan Senger, S. Senger, M. Convery, 2007, Bioorganic & medicinal chemistry letters.

The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs.

Stefan Senger, Savvas Kleanthous, Iain M McLay, 2011, Bioorganic & medicinal chemistry letters.

Factor Xa inhibitors: S1 binding interactions of a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides.

Stefan Senger, Matthew Campbell, Savvas Kleanthous, 2007, Journal of medicinal chemistry.

Identification of potent and selective oxytocin antagonists. Part 2: further investigation of benzofuran derivatives.

Michael J Allen, Paul G Wyatt, Mamta Patel, 2002, Bioorganic & medicinal chemistry letters.

Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.

Richard E Mewshaw, L. Schechter, D. Smith, 2005, Bioorganic & medicinal chemistry letters.

Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines.

Xiaojie Shi, Richard E Mewshaw, L. Schechter, 2004, Journal of medicinal chemistry.

Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs.

Stefan Senger, Matthew Campbell, Savvas Kleanthous, 2008, Bioorganic & medicinal chemistry letters.

Structure and property based design of factor Xa inhibitors: pyrrolidin-2-ones with aminoindane and phenylpyrrolidine P4 motifs.

Stefan Senger, Savvas Kleanthous, Robert J Young, 2011, Bioorganic & medicinal chemistry letters.

Structure- and property-based design of factor Xa inhibitors: pyrrolidin-2-ones with acyclic alanyl amides as P4 motifs.

Stefan Senger, Matthew Campbell, Savvas Kleanthous, 2006, Bioorganic & medicinal chemistry letters.

Novel synthesis of a conformationally-constrained analog of DDATHF

Edward C. Taylor, Baihua Hu, Ping Zhou, 1997 .